US03843E1047
US03843E1047
Aquestive Therapeutics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 599.95M EUR | 522.13M EUR | 515.78M EUR |
Enterprise Value | 557.98M EUR | 482.67M EUR | 448.63M EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | -8.39x | -- | -- |
Price to Sales | 11.09x | 9.65x | 10.26x |
Price to Book | -- | -- | -- |
EV/Revenue | 10.32x | 8.92x | 8.92x |
EV/EBITDA | -10.69x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -4.48% | -8.8% | -8.59% |